ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 681114 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 681114; 2) Community: the network communities that were significantly associated with the response to NSC 681114; 3) Molecule: the relationships between components within communities and NSC 681114; 4) MDR: the compounds that were significantly associated with the NSC 681114.

NSC Compound Enrichment Correlation
NSC 710895 3-[(1H-Indol-3-ylethyl)amino]-2-(3-isopropoxyphenyl)-2H-pyrido[4,3-e]-1,2,4,-thiadiazine 1,1-dioxide 0.0342636096654271 0.13795346
NSC 723732 8-{4-[6-(4-flurophenyl)-2-methyl-4-pyrimidinyloxy]butoxy}-7- methoxy-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a ][1,4]diazepin-5-one 0.0342636096654271 0.14930006
NSC 737231 Null 0.0342636096654271 0.36909443
NSC 740 Methotrexate 0.0342636096654271 0.39889864
NSC 740476 Null 0.0342636096654271 0.27288242
NSC 747461 Null 0.0342636096654271 -0.20592941
NSC 748715 Null 0.0342636096654271 0.25608515
NSC 762559 Null 0.0342636096654271 -0.041850052
NSC 763059 Paracymene-ruthenium(II)-[N-(3-(1H-imidazol-1-yl)propyl)-4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8 tetrahydronaphthalen-2-yl)vinyl)benzamide] dichloride 0.0342636096654271 0.1621667
NSC 255104 Des-O-methylgeldanamycin 0.0342636096654276 -0.035902675
Total:60  Current:42    [First] [Prev] [Next] [Last]